Hjem › Burkitts lymfom › North Carolina › Greenville
Kliniske studier for Burkitts lymfom i Greenville, NC
5 studier for Burkitts lymfom søker deltakere på steder i og rundt Greenville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
RekruttererFase 3
- East Carolina University, Greenville
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
RekruttererFase 2
- East Carolina University, Greenville
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
RekruttererFase 2
- East Carolina University, Greenville
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
RekruttererFase 3
- East Carolina University, Greenville
Registry of Older Patients With Cancer
RekruttererObservasjonsstudie
- East Carolina University, Greenville
Burkitts lymfom-studier i andre byer
- Houston, TX21 studier
- Philadelphia, PA16 studier
- Milwaukee, WI16 studier
- Chicago, IL15 studier
- Cincinnati, OH13 studier
- New York City, NY13 studier
- Atlanta, GA12 studier
- Aurora, CO11 studier
- Seattle, WA11 studier
- Durham, NC10 studier
- Boston, MA10 studier
- Kansas City, MO10 studier
Andre studier i Greenville
- Akut myelogen leukemi10 studier
- Sigdcelleanemi9 studier
- Idiopatisk trombocytopenisk purpura6 studier
- Hjertesvikt6 studier
- Kronisk lymfatisk leukemi5 studier
- Fedme5 studier
- Type 2-diabetes5 studier
- Blodlidelser5 studier
- Kreft (alle typer)4 studier
- Autoimmune sykdommer4 studier
- Myeloproliferative neoplasmer4 studier
- Myelodysplastiske syndromer4 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.